|
HY-103370-1mg
|
MedChemexpress LLC
|
Talniflumate [CAS 66898-62-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-103370-10mg
|
MedChemexpress LLC
|
Talniflumate [CAS 66898-62-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-103370-5mg
|
MedChemexpress LLC
|
Talniflumate [CAS 66898-62-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-103370-50mg
|
MedChemexpress LLC
|
Talniflumate [CAS 66898-62-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-106224-1mg
|
MedChemexpress LLC
|
Orexin A (human, rat, mouse) [CAS 205640-90-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106224-5mg
|
MedChemexpress LLC
|
Orexin A (human, rat, mouse) [CAS 205640-90-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107343-100mg
|
MedChemexpress LLC
|
Docosahexaenoic acid ethyl ester [CAS 81926-94-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107343-250mg
|
MedChemexpress LLC
|
Docosahexaenoic acid ethyl ester [CAS 81926-94-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107343-500mg
|
MedChemexpress LLC
|
Docosahexaenoic acid ethyl ester [CAS 81926-94-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107343S1-100ug
|
MedChemexpress LLC
|
Docosahexaenoic acid ethyl ester-d5-1 [CAS 159146-01-7]
|
|
|
|
|
HY-109591A-1mg
|
MedChemexpress LLC
|
Oleoyl coenzyme A (lithium) [CAS 188824-37-5]
|
|
|
|
|
HY-109591A-5mg
|
MedChemexpress LLC
|
Oleoyl coenzyme A (lithium) [CAS 188824-37-5]
|
|
|
|
|
HY-110155-10mg
|
MedChemexpress LLC
|
LM11A-31 (dihydrochloride) [CAS 1243259-19-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-110155-100mg
|
MedChemexpress LLC
|
LM11A-31 (dihydrochloride) [CAS 1243259-19-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-110155-25mg
|
MedChemexpress LLC
|
LM11A-31 (dihydrochloride) [CAS 1243259-19-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-110155-5mg
|
MedChemexpress LLC
|
LM11A-31 (dihydrochloride) [CAS 1243259-19-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-110155-50mg
|
MedChemexpress LLC
|
LM11A-31 (dihydrochloride) [CAS 1243259-19-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-110155-500mg
|
MedChemexpress LLC
|
LM11A-31 (dihydrochloride) [CAS 1243259-19-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-112052-10mg
|
MedChemexpress LLC
|
Aminomalonic acid [CAS 1068-84-4]
|
|
Cancer-programmed cell death
|
|
|
HY-112052-100mg
|
MedChemexpress LLC
|
Aminomalonic acid [CAS 1068-84-4]
|
|
Cancer-programmed cell death
|
|
|
HY-112052-5mg
|
MedChemexpress LLC
|
Aminomalonic acid [CAS 1068-84-4]
|
|
Cancer-programmed cell death
|
|
|
HY-112052-50mg
|
MedChemexpress LLC
|
Aminomalonic acid [CAS 1068-84-4]
|
|
Cancer-programmed cell death
|
|
|
HY-113058-10mg
|
MedChemexpress LLC
|
3-Hydroxyoctanoic acid [CAS 14292-27-4]
|
|
|
|
|
HY-113058-25mg
|
MedChemexpress LLC
|
3-Hydroxyoctanoic acid [CAS 14292-27-4]
|
|
|
|
|
HY-113058-5mg
|
MedChemexpress LLC
|
3-Hydroxyoctanoic acid [CAS 14292-27-4]
|
|
|
|
